In-situ itraconazole treatment improves survival rate during an amphibian chytridiomycosis 1 epidemic 2 3
Introduction
Emerging infectious diseases are a growing threat to both humans and biodiversity globally (Daszakre-release rather than treating them in-situ (Hardy et al. 2015) . Environmental persistence of Bd 154 zoospores (Johnson & Speare 2003; and the possible presence of infected sympatric 155 amphibians (Daszak et al. 1999 ) mean animals treated in-situ would likely be exposed to Bd both 156 throughout and after the treatment period, increasing the likelihood of their extirpation (Retallick et 157 al. 2004; Mitchell et al. 2008) . Antifungal treatment in a field setting, however, might enable treated 158 animals to persist by lowering their Bd infection load until the initial epidemic has passed (Briggs et 159 al. 2010; Vredenberg et al. 2010 ). There is some evidence that animals surviving the epidemic phase 160 persist by tolerating subsequent lower levels and frequencies of infection (Retallick et al. 2004 ; 161 Briggs et al. 2010 ). Also, repeated infection and clearance of Bd might allow the development of 162 resistance in some species ). 163 164
The Caribbean is a global hotspot of amphibian endemism, with 99% of the 197 species being 165 endemic (Fong et al. 2015) , and it has the highest proportion (84%) of threatened amphibians within 166 a region (Stuart et al. 2008) . One species, the mountain chicken frog (Leptodactylus fallax), has 167 suffered a precipitous decline due to chytridiomycosis (Magin 2003 Montserrat and this was rapidly followed by epidemic mortality across the island (Mountain Chicken  173 Recovery Programme 2014). The characteristically rapid rates of chytridiomycosis-driven declines 174 (Lips et al. 2006 ), such as those observed in L. fallax, limit the time available to react effectively. 175 Interventions that can reduce rates of decline can be valuable for providing extra time to implement 176 further conservation actions. 177 178
In this study we report the use of itraconazole treatment in a field setting in an attempt to mitigate 179 the impact of epidemic chytridiomycosis. We assess whether in-situ antifungal treatment is a 180 feasible and effective method for improving the survival of a critically endangered species 181 undergoing a precipitous decline due to epidemic chytridiomycosis. L. fallax is an ideal species to use 182 as a model for such in-situ treatment as it is a large territorial animal with predictable behaviours, 183 making it relatively easy to detect and individually identify. Also, the species has been studied for 184 over ten years on Montserrat, so there is a great deal of knowledge about its distribution, 185 abundance and behaviour and field sites were already established (Garcia et In order to reduce the potentially very large number of candidate models, we used a two-step 288 process modified from Lebreton et al. (1992) to estimate parameters in the CMR analysis. In step 289 one, we used the top model for survival and recapture probabilities from a preliminary Burnham 290 dead recoveries analysis (Burnham 1993 ) to model dead recovery and transition rates. In step two, 291
we used the best estimates of dead recovery and transition rates from step one to model survival 292 and recapture probabilities. This led to the generation of a model set of 128 models. 293 294
Model selection and goodness of fit 295
We based model selection on AICc. To account for model selection uncertainty, robust estimates of 296 the parameters were computed using weighted model averaging (Burnham & Anderson 2002 ). 297 298
We performed a preliminary diagnostic goodness of fit test for the multi-state models in program U-299 CARE (Choquet et al. 2009 ) which detected slight over-dispersion and so and we altered the variance 300 inflation factor to 1.15 and the adjusted QAICc was used for model selection. 301 302
Summed Akaike weight evidence ratios were used to examine the support for dependencies in the 303 models. The strength of the support provided by the evidence ratios was extracted from In order to predict how treatment with itraconazole would have affected the entire sampled 308 population had it been applied across all frogs in this study, we produced a deterministic population 309 model in a susceptible-infected-susceptible (SIS) framework using the transition and survival rate 310
estimates from the CMR modelling. We excluded any recruitment to the adult population as no 311 nests have been recorded on Montserrat since the onset of the chytridiomycosis epidemic. We 312 defined population extinction as population size below 1. 313 314
We produced two versions of this model for a population of 228 frogs (the number of unique 315 captures in this study). The first assumed that all frogs were treated at the same rate as the treated 316 frogs in this study using the model averaged CMR transition and survival rate estimates for the IT 317 group. We modelled the second population as untreated, using the model averaged CMR parameter 318 estimates for the control groups. We initiated the simulation with one infected individual. The 319 number of frogs in each state at each time step was calculated using the matrix below, following the 320 notation in Lebreton et al. (2009) 
where:
and:
In order to include model-averaged parameter uncertainty from the CMR models, we made two 330 further models for each group, the shortest and longest times to extinction. To make the lowest time 331
to extinction model we used the lower 95% CI estimate for the rate of loss of infection and the upper 332 95% CI estimates for infection and mortality rates. The opposite 95% CIs were used to make the 333 longest time to extinction model. We present only the mean model graphically. 334 335
Results

336
In total we made 1735 captures of 228 frogs. We caught frogs assigned to the IT group (841 captures 337 of 80 frogs) more often in both absolute terms and relative to the group size than frogs from the 338 SWC group (326 captures of 42 frogs) and the NBC group (482 captures of 106 frogs). The sex ratio 339 was circa 1:1 in each treatment group. Frogs with clinical signs of chytridiomycosis were found 340 throughout the study and in all groups. 341 342
By the end of the study, 22% (n=50) of the frogs had been found dead (SWC=21% (n=9), NBC=18% 343 (n=19), IT=28% (n=22)). The proportion of animals known to be extant was greatest in the IT group 344 throughout the study, and this was especially evident towards the end of the study period (Fig. 2) Fig. 3 ). All of the most parsimonious models, 384 however, included a second estimate for the IT group when treatment ended: the estimate 385 decreased to a value similar to the control groups (0.795, 95% CI = 0.709-0.864). Uninfected animals 386 had a higher weekly survival rate than Bd infected animals in both the IT (0.988, 95% CI = 0.972-387 0.995, effect size = 9.4%) and control groups (0.974, 95% CI = 0.939-0.987, effect size = 20.3%; Fig.  388 3). 389 390
Each of the most parsimonious models contained a difference in recapture rate between Bd infected 391 and uninfected animals, and with time dependency. The top models also contained a difference in 392 the recapture rate of the IT and control groups, with limited support for a difference in the NBC and 393 SWC groups (summed Akaike weight = 0.877; evidence ratio = 7.1). There was very weak support for 394 an interaction between infection state and treatment group (summed Akaike weight = 0.095, 395 evidence ratio = 0.1). As time dependent recapture probability was best supported, mean estimates 396 averaged across each occasion are presented (Fig. 4 -full results) . Model averaged parameter 397 estimates showed that Bd infection increased recapture probability by a mean of 99.1% in the IT 398 group (Uninfected(U) = 0.354, Infected(I) = 0.711), 120% in the SWC group (U = 0.310, I = 0.686), and 399 136% in the NBC group (U = 0.270, I = 0.637). Based on these estimates, the recapture rate of Bd 400 infected animals in the IT group was 3.6% greater than the SWC group and 11.6% higher than the 401 NBC group. The recapture rate of uninfected animals in the IT group was 14.1% greater than the 402 SWC group and 31.1% higher than in the NBC group. During the post-treatment period, the infection rate in the IT group increased from that seen in the 467 treatment period to that seen in the control groups. The Bd infection intensity also increased in the 468 IT frogs from the levels found during the treatment period to those found in the control animals. Using the mean parameter estimates from the CMR analysis, our population models predict a delay 486 of 75 weeks to population extinction for an itraconazole-treated population compared to an 487 untreated population; i.e. an approximated 60% increase in time to extinction. Whilst in-situ 488 itraconazole treatment at the intensity conducted in our study would not prevent population 489 extinction, it would prolong the period until extinction, thus allowing time to implement other 490 conservation measures, such as the establishment of an ex-situ conservation breeding population. 491
The with itraconazole has the potential to maintain a susceptible population through seasonally high risk 495 periods. 496 497
In the current study, itraconazole treatment was applied for only 15 weeks, which was insufficient 498 time for the epidemic phase to come to an end and therefore high infection loads likely persisted in 499 untreated syntopic animals throughout this period. Should treatment have continued beyond the 500 epidemic phase, it is possible that a longer term benefit from itraconazole treatment, such as the 501 prevention of population extinction, could have occurred as exposure rates and inoculation doses 502 decreased and this would be worth investigating in other systems. 503 504
Previous studies have predicted the importance of Bd infection state in species detectability (Jenelle 505 et al. 2007) , with reduced recapture probability of infected animals in populations where Bd is 506 endemic (Murray et al. 2009 ). Other studies have provided no evidence for a difference in recapture 507 rates of infected vs uninfected animals (Phillot et al. 2013) , therefore this effect is likely species-and 508 infection-load-specific. In our study, we found infection state to be an important predictor of 509 detectability, but with higher recapture rates for infected animals. A possible reason for this 510 difference from previous studies is that L. fallax is a large bodied and highly territorial species 511 (Martin et al. 2007 ), thus sick animals will be more easily detected than cryptic species such as tree 512 frogs. Our field observations showed that L. fallax frogs with clinical chytridiomycosis were lethargic, 513 active during the day, aggregated in ponds, and displayed decreased capture avoidance (authors' 514 unpublished observations). It is possible that the increased recapture probability of infected animals 515 may have increased the efficacy of itraconazole treatment, by increasing the likelihood of capture 516 and, hence, treatment of infected animals. This is unlikely to be the case for all amphibian species. 517 518
We found that animals in the IT group had higher recapture probabilities than those in the control 519 groups. At first, this seems to contradict our finding that infected animals were more likely to be 520 recaptured than uninfected animals (with a higher proportion of the IT group being uninfected than 521 the control groups). This result, however, appears to be due to a higher recapture probability of 522 uninfected animals in the IT group compared to the control groups (Fig. 4) . Itraconazole treatment 523 has been reported to cause lethargy of some amphibians under laboratory conditions (Brannelly et 524 al. 2012 ), but in these cases the drug doses were higher as they were administered daily compared 525 to on average weekly in this study. Importantly, the apparent behavioural differences of animals in 526 the IT and control groups did not impact survival sufficiently to negate from the increased survival 527 resulting from itraconazole treatment. 528 529
The NBC group also had lower recapture probabilities than either the IT or the SWC group. This could 530 be because animals were assigned to the NBC group after the other groups and the first animals 531 caught and assigned to the IT and SWC groups might have been more territorial and, hence, more-532 easily detected, and recaptured. 533 534
There has been little research into the potential for the development of antifungal resistance by Bd. 535 Such resistance has been widely reported in human fungal pathogens, including to triazoles, the 536 group of fungicides which includes itraconazole (e.g. Kanafani & Perfect 2008 total live) using model averaged parameter estimates generated by the multi-state mark-recapture 933 modelling for the (a) control group (untreated population) and (b) itraconazole treatment group 934 (Itraconazole treated population). 935
